Literature DB >> 3514339

Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells.

A Terano, H Hiraishi, S Ota, T Sugimoto.   

Abstract

Aim of this study was to investigate the effect of geranylgeranylacetone (GGA) on mucus synthesis and secretion in rat gastric cultured cells, and their relationship to prostaglandin (PG) synthesis. Rate of mucus synthesis was estimated by incorporation of 3H-glucosamine into the cultured cells. Release of 3H-glucosamine from the cells, which were preincubated in the medium containing the radioactive isotope, into the culture media was measured for the evaluation of mucus secretion. PG production by the cultured cells was measured by radioimmunoassay. GGA increased glycoprotein synthesis in a dose-dependent manner (p less than 0.01). Secretion of mucus from cultured cells was also significantly enhanced by GGA. GGA did not significantly increase PG (E2 and I2) production. These results indicate that GGA has the ability to stimulate mucus production by the gastric epithelial cells, and this action may play an important role in protective effect of GGA. It is, however, unlikely that this effect of GGA is mediated by endogenous PGs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514339     DOI: 10.1159/000199296

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

1.  Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone.

Authors:  T Iwao; A Toyonaga; M Ikegami; H Shigemori; K Oho; M Sumino; K Tanikawa
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

2.  Effect of tetraprenylacetone, a novel anti-ulcer agent, on healing process of ethanol-induced gastric injury in rat.

Authors:  A Terano; J Shiga; S Ota; H Hiraishi; H Mutoh; T Sugimoto
Journal:  Gastroenterol Jpn       Date:  1989-02

3.  Gastric mucosal protection via enhancement of MUC5AC and MUC6 by geranylgeranylacetone.

Authors:  Su Youn Nam; Nayoung Kim; Chang Soo Lee; Kee Don Choi; Hye Seung Lee; Hyun Chae Jung; In Sung Song
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

Review 4.  Isoprenoids: remarkable diversity of form and function.

Authors:  Sarah A Holstein; Raymond J Hohl
Journal:  Lipids       Date:  2004-04       Impact factor: 1.880

5.  A role for HSP70 in protecting against indomethacin-induced gastric lesions.

Authors:  Shintaro Suemasu; Ken-Ichiro Tanaka; Takushi Namba; Tomoaki Ishihara; Takashi Katsu; Mitsuaki Fujimoto; Hiroaki Adachi; Gen Sobue; Koji Takeuchi; Akira Nakai; Tohru Mizushima
Journal:  J Biol Chem       Date:  2009-05-13       Impact factor: 5.157

6.  Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.

Authors:  Kohei Kamei; Yoshikazu Kubo; Naho Kato; Ryo Hatazawa; Kikuko Amagase; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2008-02-28       Impact factor: 3.199

7.  Geranylgeranylacetone induces cyclooxygenase-2 expression in cultured rat gastric epithelial cells through NF-kappaB.

Authors:  Tsutomu Nishida; Yuki Yabe; Hai Ying Fu; Yujiro Hayashi; Kayoko Asahi; Hiroshi Eguchi; Shingo Tsuji; Masahiko Tsujii; Norio Hayashi; Sunao Kawano
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.487

8.  The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries.

Authors:  Jing Zhao; Yihong Fan; Wu Ye; Wen Feng; Yue Hu; Lijun Cai; Bin Lu
Journal:  Gastroenterol Res Pract       Date:  2019-06-18       Impact factor: 2.260

Review 9.  Gut Microbiota in NSAID Enteropathy: New Insights From Inside.

Authors:  Xianglu Wang; Qiang Tang; Huiqin Hou; Wanru Zhang; Mengfan Li; Danfeng Chen; Yu Gu; Bangmao Wang; Jingli Hou; Yangping Liu; Hailong Cao
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.